Your browser doesn't support javascript.
loading
Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features.
Wei, Wenjing; Zhang, Shuai; Fleming, Joy; Chen, Ying; Li, Zihui; Fan, Shanghua; Liu, Yi; Wang, Wei; Wang, Ting; Liu, Ying; Ren, Baiguang; Wang, Ming; Jiao, Jianjian; Chen, Yuanyuan; Zhou, Ying; Zhou, Yafeng; Gu, Shoujin; Zhang, Xiaoli; Wan, Li; Chen, Tao; Zhou, Lin; Chen, Yong; Zhang, Xian-En; Li, Chuanyou; Zhang, Hongtai; Bi, Lijun.
Affiliation
  • Wei W; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Zhang S; University of the Chinese Academy of Sciences, Beijing, China.
  • Fleming J; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Chen Y; University of the Chinese Academy of Sciences, Beijing, China.
  • Li Z; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Fan S; School of Stomatology and Medicine, Foshan University, Foshan, China.
  • Liu Y; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Wang W; Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Wang T; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Liu Y; Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Ren B; Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Wang M; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Jiao J; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Chen Y; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Zhou Y; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Zhou Y; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Gu S; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Zhang X; School of Stomatology and Medicine, Foshan University, Foshan, China.
  • Wan L; School of Stomatology and Medicine, Foshan University, Foshan, China.
  • Chen T; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Zhou L; School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, China.
  • Chen Y; School of Stomatology and Medicine, Foshan University, Foshan, China.
  • Zhang XE; Key Laboratory of RNA Biology and National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Li C; Center for Tuberculosis Control of Guangdong Province, Guangzhou, China; and.
  • Zhang H; Center for Tuberculosis Control of Guangdong Province, Guangzhou, China; and.
  • Bi L; School of Stomatology and Medicine, Foshan University, Foshan, China.
FASEB J ; 33(1): 1496-1509, 2019 01.
Article in En | MEDLINE | ID: mdl-29979631
ABSTRACT
Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) systems are prokaryotic adaptive immune systems against invading nucleic acids. CRISPR locus variability has been exploited in evolutionary and epidemiological studies of Mycobacterium tuberculosis, the causative agent of tuberculosis, for over 20 yr, yet the biological function of this type III-A system is largely unexplored. Here, using cell biology and biochemical, mutagenic, and RNA-seq approaches, we show it is active in invader defense and has features atypical of type III-A systems mature CRISPR RNA (crRNA) in its crRNA-CRISPR/Cas protein complex are of uniform length (∼71 nt) and appear not to be subject to 3'-end processing after Cas6 cleavage of repeat RNA 8 nt from its 3' end. crRNAs generated resemble mature crRNA in type I systems, having both 5' (8 nt) and 3' (28 nt) repeat tags. Cas6 cleavage of repeat RNA is ion dependent, and accurate cleavage depends on the presence of a 3' hairpin in the repeat RNA and the sequence of its stem base nucleotides. This study unveils further diversity among CRISPR/Cas systems and provides insight into the crRNA recognition mechanism in M. tuberculosis, providing a foundation for investigating the potential of a type III-A-based genome editing system.-Wei, W., Zhang, S., Fleming, J., Chen, Y., Li, Z., Fan, S., Liu, Y., Wang, W., Wang, T., Liu, Y., Ren, B., Wang, M., Jiao, J., Chen, Y., Zhou, Y., Zhou, Y., Gu, S., Zhang, X., Wan, L., Chen, T., Zhou, L., Chen, Y., Zhang, X.-E., Li, C., Zhang, H., Bi, L. Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Bacterial / CRISPR-Cas Systems / Mycobacterium tuberculosis Language: En Journal: FASEB J Journal subject: BIOLOGIA / FISIOLOGIA Year: 2019 Document type: Article Affiliation country: China Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Bacterial / CRISPR-Cas Systems / Mycobacterium tuberculosis Language: En Journal: FASEB J Journal subject: BIOLOGIA / FISIOLOGIA Year: 2019 Document type: Article Affiliation country: China Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA